Were You Diagnosed with Cancer After Using Dupixent?
You may be entitled to significant compensation
Research published in JAMA Dermatology found that Dupixent users face a 4.5 times higher risk of developing cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer.
If you used Dupixent for eczema or asthma and were later diagnosed with CTCL, mycosis fungoides, or Sézary syndrome, you may qualify for a lawsuit against manufacturers Sanofi and Regeneron.
How It Works
Step 1: Answer a few quick questions below (takes less than 2 minutes)
Step 2: An experienced mass tort attorney reviews your information
Step 3: If you qualify, an attorney contacts you to discuss your case
Step 4: No cost to you unless you win your case
Free Case Evaluation
Answer a few questions to see if you qualify:
Why File a Dupixent Lawsuit?
Compensation may include:
- All medical expenses for diagnosis and treatment
- Lost wages and reduced earning capacity
- Pain and suffering from cancer and treatments
- Wrongful death damages for family members
Based on similar pharmaceutical cases, settlements may range from $250,000 to over $5 million depending on your specific situation.
Frequently Asked Questions
How much does it cost?
Nothing. Attorneys work on contingency—you pay nothing unless you win.
How long does the filing process take?
The initial intake takes around 45 minutes. If you qualify, your attorney handles all paperwork and filing. You don't need to appear in court during the initial stages.
Is my information confidential?
Yes. Your information is protected and only shared with attorneys who may be able to help.
What if I'm still using Dupixent?
You can still file. Consult your doctor before stopping any medication.
Your privacy is protected. By submitting this form, you agree to our Privacy Policy and Terms of Service.